Safest Antihistamines During Breastfeeding
Loratadine and cetirizine are the first-line antihistamines for breastfeeding mothers, with extensive safety data showing minimal breast milk transfer and relative infant doses well below the 5% safety threshold. 1, 2
Primary Recommendations
The European Respiratory Society specifically recommends loratadine or cetirizine as preferred antihistamines during breastfeeding because they have been most extensively studied and are classified as "compatible" with breastfeeding in international guidelines. 2
Key Safety Data
- Cetirizine transfers minimally into breast milk with a relative infant dose (RID) of only 1.9%, far below the 5% safety threshold 3
- Loratadine has similarly low transfer with RID ranging from 0.3-4.5% depending on the specific agent 4
- Maximum cetirizine milk concentrations average 41.0 μg/L, occurring approximately 2.4 hours after intake, with a half-life in milk of 7.0 hours 3
- The absolute infant dose for cetirizine is estimated at only 2.5 μg/kg per day 3
Practical Considerations
No Need for Pump-and-Dump
- There is no need to pump and discard breast milk after taking antihistamines at recommended doses 1
Special Monitoring for Young Infants
- Exercise extra caution with infants less than 6 weeks of age (corrected for gestational age) due to immature hepatic and renal function 1
- Watch specifically for excessive drowsiness or feeding difficulties in very young infants 1, 2
Theoretical Milk Production Concerns
- All antihistamines may theoretically reduce milk production, though this has not been clinically demonstrated with cetirizine or loratadine 2, 5
Dosing Adjustments
Renal Impairment
- Halve the cetirizine dose in moderate renal impairment (creatinine clearance 10-20 mL/min) 5
- Avoid cetirizine entirely in severe renal impairment (creatinine clearance <10 mL/min) 5
Important Caveats
Discrepancy with FDA Labeling
- Despite cetirizine being listed as "not recommended" during breastfeeding in FDA labels, international respiratory societies including the European Respiratory Society recommend it alongside loratadine based on actual safety data 2
- This represents a common pitfall where product labels lag behind clinical evidence